Home With TablO outcoMEs (HOME) Registry

NCT04526301 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-09-23

No results posted yet for this study

Summary

Prospective, multicenter, single arm, post-market study to evaluate real world clinical outcomes in ESRD patients receiving in-home dialysis on the Tablo Hemodialysis System.

Conditions

Interventions

DEVICE

Tablo Hemodialysis System

Home hemodialysis treatments \~4 times a week.

Sponsors & Collaborators

  • Outset Medical

    lead INDUSTRY

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-14
Primary Completion
2024-07-31
Completion
2024-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04526301 on ClinicalTrials.gov